BUELACH, Switzerland and LONDON, UK, April 18, 2019 – BIOLUX P-III 24-month study data supports safe and effective clinical performance of the Passeo®-18 LuxTM drug-coated balloon (DCB) for patients with infrapopliteal artery lesions and...
BUELACH, Switzerland and LONDON, UK, April 18, 2019 – BIOLUX P-III 24-month study data supports safe and effective clinical performance of the Passeo®-18 LuxTM drug-coated balloon (DCB) for patients with infrapopliteal artery lesions and...
BUELACH, Switzerland and LONDON,...